Otsuka Group News

Keyword search

Add search criteria

Search by company

Otsuka Holdings
Otsuka Pharmaceutical
Otsuka Pharmaceutical Factory
Taiho Pharmaceutical
Otsuka Warehouse
Otsuka Chemical
Otsuka Foods
Otsuka Medical Devices
Other

Search by category^*

Pharmaceuticals Business
Nutraceuticals Business
Consumer Products Business
Others
Products
R&D
Personnel
Corporate

* Business categories are based on the business segments described in the financial announcements.

Search by release date

-

Showing 100 results

Search by release date:: Jan, 2014 ～ Dec, 2014

December 29, 2014
Other

Otsuka Techno Announces Personnel Changes
December 26, 2014
Otsuka Holdings

New Drug Application Approval of TAKECAB® for the treatment of Acid-related Diseases in Japan
December 26, 2014
Otsuka Pharmaceutical

New Drug Application Approval of TAKECAB® for the Treatment of Acid-related Diseases in Japan
December 24, 2014
Taiho Pharmaceutical

Taiho Pharmaceutical Completes Submission of TAS-102 New Drug Application to the US Food and Drug Administration for the Treatment of Refractory Metastatic Colorectal Cancer
December 23, 2014
Otsuka Pharmaceutical

ARIAD and Otsuka Announced Co-development and Commercialization Agreement for Iclusig® to Treat Leukemias in Japan and Nine Other Asian Countries
December 19, 2014
Otsuka Pharmaceutical

Otsuka Pharmaceutical Saga Nutraceuticals Research Institute Strengthens Focus on Sports Nutrition Completion of New Artificial Environment Control Room
December 18, 2014
Otsuka Pharmaceutical

Otsuka Pharmaceutical Acquired US-based FoodState Inc. Growing Supplement Business Through New Channels
December 18, 2014
Taiho Pharmaceutical

Antitumor Agent "Abraxane® I.V. Infusion 100 mg" Approved for Additional Indication of Unresectable Pancreatic Cancer
December 13, 2014
Otsuka Holdings

Otsuka Pharmaceutical Commences Tender Offer to Acquire All Outstanding Shares of Avanir Pharmaceuticals
December 11, 2014
Otsuka Holdings

OTSUKA AND LUNDBECK’S BREXPIPRAZOLE DEMONSTRATES STATISTICALLY SIGNIFICANT EFFECTS IN NEW PHASE III STUDIES IN ADULT PATIENTS WITH SCHIZOPHRENIA PRESENTED AT THE AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING
December 11, 2014
Otsuka Pharmaceutical

Otsuka And Lundbeck's Brexpiprazole Demonstrates Statistically Significant Effects In New Phase III Studies In Adult Patients With Schizophrenia Presented At The American College Of Neuropsychopharmacology Annual Meeting
December 10, 2014
Otsuka Holdings

OTSUKA AND LUNDBECK PRESENT PHASE III DATA ON BREXPIPRAZOLE AS ADJUNCTIVE THERAPY IN ADULT PATIENTS WITH MAJOR DEPRESSION AT THE AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING
December 10, 2014
Otsuka Pharmaceutical

Otsuka And Lundbeck Present Phase III Data on Brexpiprazole As Adjunctive Therapy In Adult Patients With Major Depression At The American College Of Neuropsychopharmacology Annual Meeting
December 8, 2014
Otsuka Holdings

U.S. FDA APPROVES THE LABELING UPDATE OF ABILIFY MAINTENA® (ARIPIPRAZOLE) FOR EXTENDED-RELEASE INJECTABLE SUSPENSION TO DESCRIBE NEW CLINICAL DATA FOR THE TREATMENT OF ACUTELY RELAPSED ADULTS WITH SCHIZOPHRENIA
December 8, 2014
Otsuka Pharmaceutical

U.S. FDA Approves The Labeling Update Of Abilify Maintena ® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clinical Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia
December 2, 2014
Otsuka Holdings

Otsuka Pharmaceutical to Acquire Avanir Pharmaceuticals Full-scale entry to neurologic diseases area widens core business presence in CNS
December 2, 2014
Otsuka Pharmaceutical

OTSUKA PHARMACEUTICAL TO ACQUIRE AVANIR PHARMACEUTICALS Full-scale entry to neurologic diseases area widens core business presence in CNS
December 1, 2014
Otsuka Holdings

Notice of Change of Representative Director (Obituary)
November 28, 2014
Otsuka Pharmaceutical

L-Cartin® FF Tablets For Carnitine Deficiencies To Be Introduced in Japan on December 5 Active Ingredient Carnitine in Free Form (FF*) to Address the Needs of Medical Field
November 21, 2014
Otsuka Pharmaceutical

Nutrition & Santé Inaugurates New Factory Expanding Production Base of the French Leader in Functional and Dietetic Foods
November 19, 2014
Otsuka Holdings

Otsuka Holdings’ Chairman and Representative Director Akihiko Otsuka receives the “Legion d’honneur” from France
November 14, 2014
Otsuka Pharmaceutical

Otsuka Group Establishes New Company in Order to Strengthen Presence in Vending Machine Market
October 27, 2014
Otsuka Holdings

Otsuka announces 2014 third quarter U.S. net sales figures of ABILIFY®
October 27, 2014
Otsuka Pharmaceutical

New product for Japanese women Nature Made Fish Oil Pearl Small Pearl-shaped Capsules Concentrated With Essential Nutritional Balance of Fish Oil
October 21, 2014
Taiho Pharmaceutical

Taiho Pharmaceutical Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer - Taiho Initiates Rolling NDA Submission for TAS-102 -
October 14, 2014
Otsuka Pharmaceutical

Otsuka Pharmaceutical's QuickNavi™-Flu Influenza Diagnostic Kit to Provide Additional Diagnosis-Related Information
October 10, 2014
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory Enters into a License Agreement on Bioengineered Pancreatic Islet “DIABECELL®” as a Treatment for Diabetes
October 1, 2014
Otsuka Pharmaceutical

Calorie Mate Recipient of "G Mark" Good Design Long Life Design Award
September 24, 2014
Otsuka Holdings

U.S. FDA ACCEPTS OTSUKA AND LUNDBECK’S FILING FOR REVIEW OF BREXPIPRAZOLE FOR THE TREATMENT OF SCHIZOPHRENIA AND AS ADJUNCTIVE THERAPY FOR THE TREATMENT OF MAJOR DEPRESSION
September 24, 2014
Otsuka Pharmaceutical

U.S. FDA Accepts Otsuka and Lundbeck's Filing for Review of Brexpiprazole for the Treatment of Schizophrenia and as Adjunctive Therapy for the Treatment of Major Depression